VRP-034

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameVRP-034
Drug Alias Namesupramolecular cationic complex of polymyxin B (Venus Medicine Research Centre)polymyxin BVRP-034
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBacterial cell wall synthesis inhibitorsAntibacterial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVenus Medicine Research Centre
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A